<img alt="" height="1" width="1" />
Leading COPD Drug Won't Harm Heart: FDA
BusinessWeek
THURSDAY, Jan. 14 (HealthDay News) -- The US Food and Drug Administration on Thursday said it found no good evidence that the Spiriva HandiHaler boosts heart risks in patients who use it to help control chronic obstructive pulmonary ...
and more »
More...